Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 0.750%10/1
-
Market price (% of par)
-
110.83%
-
Total 13F principal
-
$340,031,200
-
Principal change
-
-$453,000
-
Total reported market value
-
$380,830,000
-
Number of holders
-
47
-
Value change
-
-$2,409,137
-
Number of buys
-
27
-
Number of sells
-
10
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 as of Q2 2017
As of 30 Jun 2017,
BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 was held by
47 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$340,031,200
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, MACKAY SHIELDS LLC, OAKTREE CAPITAL MANAGEMENT LP, Calamos Advisors LLC, JPMORGAN CHASE & CO, CREDIT SUISSE AG/, BAKER BROS. ADVISORS LP, LINDEN ADVISORS LP, and TENOR CAPITAL MANAGEMENT Co., L.P..
This page lists
47
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.